Back to search
FDAFDA · Food and drugs·Recall number D-383-2014

Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01

Published January 1, 2014 · Recall initiated: October 22, 2013

Summary

FDA records drug Class II recall D-383-2014, published January 1, 2014 and initiated October 22, 2013. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 12,521 bottles; Lot: Lots DE9898, DE9900, DE9903, DE9908, DE9911. Exp. 06/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin

What to do

Voluntary: Firm initiated · Letter

Get an email if TACROLIMUS has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TACROLIMUS
Manufacturer
Sandoz Incorporated
Distributor
Nationwide
UPC
0307812103012
Lot
Lots DE9898, DE9900, DE9903, DE9908, DE9911. Exp. 06/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01 recalled?

Yes. FDA published recall D-383-2014 on January 1, 2014. Reported hazard: Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TACROLIMUS. UPC: 0307812103012.